Debbie Feinstein heads the firm's Global Antitrust group, and brings a wealth of experience to her practice in advising clients on a range of antitrust challenges before US antitrust authorities. She recently re-joined the firm from the US Federal Trade Commission (FTC), where she was Director of the Bureau of Competition. In that capacity, she was responsible for supervising the investigation and enforcement of the US antitrust laws against anticompetitive mergers and conduct. During her tenure, the FTC had substantial litigation success and a number of major merger wins, including challenges to Sysco Corp.'s acquisition of rival US Foods Inc., and Staples Inc.'s merger with Office Depot Inc. She had previously served at the FTC from 1989 to 1991 as Assistant to the Director of the Bureau of Competition and Attorney Advisor.

Throughout her career, Ms. Feinstein has focused on merger and acquisition reviews by antitrust enforcement agencies in the United States and globally, as well as civil investigations and litigation. Her industry experience is broad, and includes retail, food, consumer products, healthcare, chemicals, and automotive parts, among others. She was an associate at Arnold & Porter from 1987 to 1989 and from 1991 to 1995. Later, as a partner, she led the firm's US Antitrust group from 2010 to 2013.

Ms. Feinstein has been consistently lauded as a leading practitioner by Chambers USA and other ranking publications. The National Law Journal named her one of the most influential women lawyers in America and Global Competition Review recognized her as global "Lawyer of the Year" and named her to its international list of the "Top 100 Women in Antitrust." She has also been ranked by Super Lawyers as being among the top 50 women lawyers in Washington, DC.

Experience

  • Sony Corporation of America and Sony/ATV Music Publishing in obtaining antitrust clearance for the client's $2.2 billion purchase of the music publishing business of EMI.
  • General Electric Co. and NBC Universal in connection with the formation of the Comcast-NBCU joint venture investigated by DOJ, FCC, and various state attorneys general.
  • General Electric Co. in its $4.3 billion acquisition of Avio, an aircraft engine parts supplier.
  • Boston Scientific Corporation, the world's largest medical device company dedicated to less-invasive medicine, in its $27 billion acquisition of Guidant. The transaction also included a $4 billion pre-closing divestiture to Abbott Laboratories of Guidant's endovascular solutions and vascular intervention businesses but allowed Boston Scientific to retain rights with respect to Guidant's drug-eluting stent portfolio.
  • Loews Cineplex Entertainment Corporation in its merger with AMC Entertainment Inc. Together the firms will own or operate 334 theatres nationwide. The matter was resolved with the DOJ and various state attorneys general with the divestiture of only 10 theatres.
  • The Kroger Co. in its $13.5 billion merger with Fred Meyer, Inc., successfully negotiated with the FTC to require the divestiture of only 8 stores. The combined company became, at the time, the largest grocery retailer in the United States.
  • General Electric Corporation's $2.1 billion acquisition of Instrumentarium OYJ, a manufacturer of high-technology medical equipment.
  • Phillip Morris and Kraft in their $18.9 billion acquisition of Nabisco Holdings Corporation, creating the world's largest food company. Negotiations with the FTC resulted in the divestiture of only minimal assets.
  • Occidental Chemical Company in the $360 million purchase of Vulcan Materials Company's chemical assets.
  • PepsiCo in its $14 billion acquisition of The Quaker Oats Company. The merger strengthened PepsiCo's food businesses and added Gatorade, the leading sports drink brand, to its portfolio.
  • Meritor Automotive in its merger with Arvin Industries to become ArvinMeritor, a leading automotive industry supplier.
  • Genzyme's acquisition of Novazyme. The acquisition combined the only two companies performing research and development on a rare disease.
  • Unilever in the acquisition of Alberto Culver and in the sale of its Lawry's & Adolph's spice/seasonings business to McCormick .

Perspectives

Competition Law in Life Sciences
Arnold & Porter Kaye Scholer, London
US Antitrust Year in Review: The Trump Administration's First Year
Arnold & Porter Kaye Scholer Webinar
The Obama Trials: The US antitrust agencies in the courtroom, 2009-2017
Global Competition Review
From Crisis to Compliance: An Antitrust/Competition Seminar
Arnold & Porter Kaye Scholer, Frankfurt
Counseling and Litigating Vertical Restraints - Exclusivity and Other Downstream Restrictions
ABA Fall Forum, Washington, DC
More

Recognition

Global Competition Review
"Top 100 Women in Antitrust" (2009, 2013, 2016)
"Lawyer of the Year" (2011)
Best Lawyers
Antitrust (2012)
Chambers USA
Antitrust: Business (2011)
More

Credentials

Education
  • JD, Harvard Law School
  • AB, University of California, Berkeley
Admissions
  • District of Columbia
Overview

Email Disclaimer